Pan, Fumin
Cheng, Jingbo
Kong, Chao
Wang, Wei
Lu, Shibao
Funding for this research was provided by:
National Natural Science Foundation of China (82102612)
R&D Program of Beijing Municipal Education Commission (KZ202210025038)
Chinese Institutes for Medical Research, Beijing (CX24PY12)
Article History
Received: 24 September 2024
Accepted: 28 May 2025
First Online: 10 June 2025
Declarations
:
: The study was approved by the ethical committee of Xuanwu Hospital Capital Medical University (No. 2023-241-002). The written informed consent was obtained from all participating patients. This clinical trial was conducted in strict accordance with the Declaration of Helsinki (Edinburgh 2000 version) and relevant Chinese clinical trial research norms and regulations.
: Not applicable.
: The authors declare no competing interests.